Summary
- Current Price
- EXAS price is unknown, with unknown change on
- Current Price All-Time High
- EXAS price vs all-time high is unknown
- Market Cap
- EXAS market cap is unknown, with unknown 1-year change
- PE Ratio
- EXAS PE ratio is unknown
- Revenue
- EXAS current annual revenue is $3.25B, up +17.69% year-over-year
- Next Earnings
- As of today, the next earnings release for EXAS has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Exact Sciences Corp |
| Ticker | NASDAQ: EXAS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | exactsciences.com |
| Employees | 7,100 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | - | |
| Price, 1D Change | - | |
| Market Cap | - | |
| - | ||
| PE Ratio | - | |
| Beta | N/A | - |
| Revenue | $3B | |
| Revenue, 1Y Change | +17.69% | |
| EPS | -$1.10 | |
| EPS, 1Y Change | +80.27% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$1.10 | |
| EPS Estimate | N/A | $0.91 |
| EPS Est. Change | N/A | +182.57% |
| Revenue | $3.25B | |
| Revenue Estimate | N/A | $3.66B |
| Revenue Est. Change | N/A | +12.73% |
| Current Price | - | |
| Price Target | - | $105.00 |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.57 | -$5.59 | -884.94% | |
| $0.34 | -$1.10 | -425.97% | |
| $0.91 | N/A | +182.57% | |
| $1.90 | N/A | +272.40% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.75B | $2.76B | +0.45% | |
| $3.23B | $3.25B | +0.54% | |
| $3.66B | N/A | +12.73% | |
| $4.11B | N/A | +26.54% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | - | |
| Price, 3Y | - | |
| Market Cap, 1Y | - | |
| Market Cap, 3Y | - | |
| Revenue, 1Y | +17.69% | |
| Revenue, 3Y | +55.78% | |
| EPS, 1Y | +80.27% | |
| EPS, 3Y | +68.83% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | - | |
| SMA 200 | N/A | - |
| SMA 200 vs Price | N/A | - |
| SMA 50 | N/A | - |
| SMA 50 vs Price | N/A | - |
| Beta | N/A | - |
| ATR | N/A | - |
| 14-Day RSI | N/A | - |
| 10-Day Volatility | N/A | - |
| 1-Year Volatility | N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $3.25B | |
| EPS | -$1.10 | |
| Gross Profit | $0.00 | |
| Gross Margin | 69.69% | |
| Operating Profit | -$99.08M | |
| Operating Margin | -3.05% | |
| Net Income | -$207.95M | |
| Net Margin | -6.40% | |
| EBITDA | $122.50M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 1.06 | |
| 2.43 | ||
| 2.17 | ||
| - | ||
| 5 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $2.40B | |
| $964.71M | ||
| $6.08B | ||
| $1.56B | ||
| $3.68B | ||
| $641.15M | ||
| Total Debt | $2.53B | |
| $39.29M | ||
| $175.87M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $3.45B | ||
| $2.36B | ||
| $984.15M | ||
| $1.94B | ||
| $221.58M | ||
| $0.00 | ||
| $4.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $491.44M | ||
| $195.12M | ||
| -$338.09M | ||
| Capex | $134.66M | |
| $356.78M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Mizuho | → | |
| Evercore ISI Group | → | |
| Stifel | → | |
| Canaccord Genuity | → | |
| Jefferies | → | |
| Benchmark | → | |
| William Blair | → | |
| Wells Fargo | → | |
| Guggenheim | → | |
| Barclays | → |
Analyst sentiment
Institutional ownership
Screeners with EXAS
FAQ
What is the ticker symbol for Exact Sciences Corp?
The ticker symbol for Exact Sciences Corp is NASDAQ:EXAS
Does Exact Sciences Corp pay dividends?
No, Exact Sciences Corp does not pay dividends
What sector is Exact Sciences Corp in?
Exact Sciences Corp is in the Healthcare sector
What industry is Exact Sciences Corp in?
Exact Sciences Corp is in the Diagnostics & Research industry
What country is Exact Sciences Corp based in?
Exact Sciences Corp is headquartered in United States
When did Exact Sciences Corp go public?
Exact Sciences Corp initial public offering (IPO) was on February 1, 2001
Is Exact Sciences Corp in the S&P 500?
No, Exact Sciences Corp is not included in the S&P 500 index
Is Exact Sciences Corp in the NASDAQ 100?
No, Exact Sciences Corp is not included in the NASDAQ 100 index
Is Exact Sciences Corp in the Dow Jones?
No, Exact Sciences Corp is not included in the Dow Jones index
When was Exact Sciences Corp last earnings report?
Exact Sciences Corp's most recent earnings report was on May 7, 2026
When does Exact Sciences Corp report earnings?
The date for Exact Sciences Corp's next earnings report has not been announced yet
Data Sources & References
- EXAS Official Website www.exactsciences.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1124140/000112414026000011/0001124140-26-000011-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1124140/000112414026000011/0001124140-26-000011-index.htm
- EXAS Profile on Yahoo Finance finance.yahoo.com/quote/EXAS
- EXAS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/exas